Related Experiment Video
Updated: Jul 5, 2025

05:18
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
1.4K
Improved Dosimetry with Daily Online Adaptive Radiotherapy for Cervical Cancer: Waltzing the Pear
1Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Summary
Daily online adaptive radiotherapy for cervical cancer allows for smaller margins, significantly improving organ at risk dosimetry and target coverage compared to standard image-guided radiotherapy.
Area of Science:
- Radiation Oncology
- Medical Physics
- Gynecologic Oncology
Background:
- Standard radiotherapy for locally advanced cervical cancer uses large margins to account for movement.
- Daily online cone-beam adaptive radiotherapy (CBART) enables real-time adjustments to treatment plans.
- Reducing margins in CBART may improve dose distribution to organs at risk (OARs) and the target volume.
Purpose of the Study:
- To evaluate the impact of reduced clinical target volume (CTV) to planning target volume (PTV) margins using daily online CBART.
- To compare OAR dosimetry and target coverage between daily online CBART and standard image-guided radiotherapy (IGRT).
Main Methods:
- Ten patients with locally advanced cervical cancer underwent chemoradiation with daily online CBART.
- CTV-to-PTV margins were reduced in CBART plans (0.5-1.0 cm) compared to standard IGRT plans (1.0-1.5 cm).
- Dosimetric parameters of adapted plans were compared to emulated IGRT plans.
Main Results:
- Daily online CBART significantly improved bowel bag dosimetry (V40 reduced by 91.3 cm³).
- Significant dose reductions were observed in the bladder and rectum.
- Improved uterocervix CTV coverage and reduced hotspots were noted with CBART compared to IGRT.
Conclusions:
- Reduced margins with daily online CBART enhance OAR dosimetry and target coverage for cervical cancer.
- Daily online CBART offers a superior alternative to standard IGRT for locally advanced cervical cancer.
- Further investigation into the clinical impact of improved dosimetry is warranted.

